Showing results (1051-1060 of 3,081) with videos related to

Sort By:
Pageof 309
Drug Safety|September 18, 2016
Role of Preemptive Genotyping in Preventing Serious Adverse Drug Events in South Korean PatientsGrace Juyun Kim, Soo Youn Lee, Ji Hye Park, et al.
Drug Safety|September 18, 2016
Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV PatientsRaymond A Tetteh, Edmund T Nartey, Margaret Lartey, et al.
Drug Safety|September 18, 2016
Prevention of Medication Errors in Hospitalized Patients: The Japan Adverse Drug Events StudyChihiro Noguchi, Mio Sakuma, Yoshinori Ohta, et al.
Drug Safety|September 18, 2016
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®Rebecca E Chandler, Kristina Juhlin, Jonas Fransson, et al.
Drug Safety|June 9, 2017
An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting SystemGeetha Iyer, Sathiya Priya Marimuthu, Jodi B Segal, et al.
Drug Safety|June 7, 2017
Overview of the Safety of Anti-VEGF Drugs: Analysis of the Italian Spontaneous Reporting SystemPaola Maria Cutroneo, Claudia Giardina, Valentina Ientile, et al.
Drug Safety|November 18, 2009
Cisplatin overdose: toxicities and managementRoger Y Tsang, Turki Al-Fayea, Heather-Jane Au
Drug Safety|November 18, 2009
Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensingNicola Alcorn, Sarah Saunders, Rajan Madhok
Drug Safety|November 18, 2009
Laboratory tests in the clinical risk management of potential drug-drug interactions: a cross-sectional study using drug-dispensing data from 100 Dutch community pharmaciesArjen F J Geerts, Fred H P De Koning, Peter A G M De Smet, et al.
Drug Safety|June 17, 2017
Lipophilic Statins and the Risk of Intracranial Hemorrhage Following Ischemic Stroke: A Population-Based StudyKieran L Quinn, Erin M Macdonald, Muhammad M Mamdani, et al.
Pageof 309